Top compounds associated with response to LILRA1


Feature Type Standardized
Nominal ANOVA
mRNA MLN2480 CTRPv2 pan-cancer AAC 0.5 2e-23
mRNA ATRA CTRPv2 pan-cancer AAC 0.25 1e-13
mRNA cabozantinib CTRPv2 pan-cancer AAC 0.24 2e-11
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.23 4e-11
mRNA Sunitinib CTRPv2 pan-cancer AAC 0.21 5e-10
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.21 2e-09
mRNA cediranib CTRPv2 pan-cancer AAC 0.3 9e-09
mRNA PD318088 CTRPv2 pan-cancer AAC 0.19 2e-08
mRNA dacarbazine CTRPv2 pan-cancer AAC 0.17 4e-08
mRNA barasertib CTRPv2 pan-cancer AAC 0.17 6e-08
Download CSV